Bol et al. [28] demonstrated that changes in the human cancer lung cell line after RK-33 and shRNA-mediated DDX3 protein inhibition were similar: G1 cell cycle arrest, deregulation of Wnt pathway and induction of apoptosis. Here, DDX3X is linked to cancer.